examined 92 TC patients and found that hypogonadism (total testosterone < 10 nmol/L and/or LH > 10 IU/L and/or androgen replacement) also presented with increased risk (OR = 4.4; p = 0.01) of MetS [24]. This evidence concerns the gene PLOD1 and hypogonadism.